Open Access
CC BY 4.0 · Journal of Health and Allied Sciences NU 2024; 14(04): 532-537
DOI: 10.1055/s-0044-1779616
Original Article

RP-HPLC-DAD Method Development and Validation for 1,3,4-Oxadiazole Derivative to Evaluate Its Forced Degradation Behavior and Stability

Shridhar Narayan Deshpande
1   Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS) Nitte (Deemed to be university), Mangalore, Karnataka, India
,
Revana Siddappa BC
1   Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS) Nitte (Deemed to be university), Mangalore, Karnataka, India
,
Kartik Bhairu Khot
2   Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences (NGSMIPS) Nitte (Deemed to be university), Mangalore, Karnataka, India
,
Gupta Dheeraj Rajesh
1   Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS) Nitte (Deemed to be university), Mangalore, Karnataka, India
,
Cynthia Lizzie Lobo
2   Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences (NGSMIPS) Nitte (Deemed to be university), Mangalore, Karnataka, India
› Institutsangaben
Preview

Abstract

In the current study, a straightforward high-performance liquid chromatographic (HPLC) approach was developed and validated to identify a novel drug compound called 5-(4-bromophenyl)-N-(2-chloro-4-nitrophenyl)-1,3,4-oxadiazol-2-amine (A3). By putting the compound's solution under hydrolytic, oxidative, and photolytic stress, the method's capacity to detect stability was put to the test. A gradient mobile phase of acetonitrile, orthophosphoric acid, and methanol (90:051:05 v/v), at a flow rate of 1.00 mL/min, was used for the chromatographic separation on a C18 column (Promosil, 5μ, 4.60 250 mm), which was maintained at 40°C and a photodiode array detector was used for detection. At concentrations between 10 and 100.00 μg/mL, Beer's rule was observed. The recovery (99.25–100%, standard deviation [SD] 5%), intraday accuracy and precision (98.62–99.91%, relative standard deviation [RSD] 5%), interday accuracy and precision (96.25–99.91%, RSD 5%), and intermediate accuracy and precision (98.10–99.91%, RSD 5%) all indicated that the developed method was reliable, repeatable, reproducible, and robust. In cases of thermal and moisture deterioration, respectively, the compound's peak resolution and selectivity factors from the nearest resolving peak revealed specificity and selectivity. The selected synthesized compound barely broke down under oxidative and alkaline hydrolytic stress. However, the compound was resistant to photolysis in neutral and acidic environments. The results of this study demonstrate the sensitivity, specificity, and selectivity of the established approach for quality control, stability testing, and preformulation investigations.



Publikationsverlauf

Artikel online veröffentlicht:
10. Juni 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Boström J, Hogner A, Llinàs A, Wellner E, Plowright AT. Oxadiazoles in medicinal chemistry. J Med Chem 2012; 55 (05) 1817-1830
  • 2 Roy PP, Bajaj S, Maity TK, Singh J. Synthesis and evaluation of anticancer activity of 1,3,4-oxadiazole derivatives against Ehrlich ascites carcinoma bearing mice and their correlation with histopathology of liver. Ind J Pharm EduRes. 2017; 15 (02) 16-25
  • 3 Ananth AH, Manikandan N, Rajan RK. et al. Design, synthesis and biological evaluation of 2- (2-Bromo-3- nitrophenyl) -5-phenyl-1, 3, 4-oxadiazole derivatives as possible anti- breast cancer agents. Chem Biodivers 2020; 17 (02) e1900659
  • 4 Dash S, Kumar BA, Singh J. Synthesis of some novel 3,5-disubstituted 1,3,4-oxadiazole derivatives and anticancer activity on EAC animal model. Med Chem Res 2011; 20: 1206-1213
  • 5 Qamar S, Hussain K, Bukhari NI, Shehzadi N, Islam M, Siddique SZ. Method development and stress degradation profile of 5-benzyl-1,3,4-oxadiazole-2-thiolstudied by UVspectroscopy. Pharm Chem J 2018; 52: 278-283
  • 6 Bakshi M, Singh S. Development of validated stability-indicating assay methods: critical review. J Pharm Biomed Anal 2002; 28 (06) 1011-1040
  • 7 Shehzadi N, Hussain K, Islam M. et al. Development and validation of a stability-indicating RP-HPLC-FLD oxadiazole-2-thiol; a novel drug candidate. Pak J Pharm Sci 2018; 34 (02) 31-45
  • 8 Ahsan MJ, Sharma J, Singh M, Jadav SS, Yasmin S. Synthesis and anticancer activity of N-aryl-5-substituted-1,3,4-oxadiazol-2-amine analogues. BioMed Res Int 2014; 2014 (01) 814984
  • 9 Ilangovan P, Sekaran A, Chenniappan S, Chaple BK. Synthesis, characterization and antimicrobial activity of 1, 3, 4-oxadiazole derivatives. J Pharm Res 2011; 4 (06) 1696-1698
  • 10 Ashtekar H, Aggarwal N, Raviraj C, Rajesh GD, Varghese N. Synthesis characterization, RP-HPLC method development and validation for qualitative estimation of (4Z) 3-methyl hydrazone. Int J Pharm Investig 2023; 13 (02) 313-320
  • 11 Li P, Wang X, Li J. et al. Quantitative and qualitative analysis of the novel antitumor and its metabolites using HPLC-UV and UPLC-QTOF-MS. Sci Rep 2015; 5 (01) 11906-11912
  • 12 Curie M. A simple HPLC method for determining brain and plasma of animals: application to a pharmacokinetic study. Acta Chromatogr 2014; 26 (02) 255-266
  • 13 Sipkina NY, Yakovlev MVPIP. Development and validation of a new HPLC method for quantification of a novel antifungal drug based on 1, 3,4-thiadiazole and its impurities. Acta Chromatogr 2019; 3 (03) 45-56
  • 14 Zhang X, Hu C. Application of quality by design concept to develop a dual gradient elution stability-indicating method for cloxacillin forced degradation studies using combined mixture-process variable models. J Chromatogr A 2017; 1514 (14) 44-53
  • 15 Dziopa F, Ahern K. A systematic literature review of the applications of Q-technique and its methodology. The Fundamentals of Q methodology 2011; 1 (07) 39-55
  • 16 Saini B, Bansal G. Isolation and characterization of a degradation product in leflunomide and a validated selective stability-indicating HPLC-UV method for their quantification. J Pharm Anal 2015; 5 (03) 207-212
  • 17 Calbiani F, Careri M, Elviri L, Mangia A, Pistarà L, Zagnoni I. Development and in-house validation of a liquid chromatography-electrospray-tandem mass spectrometry method for the simultaneous determination of Sudan I, Sudan II, Sudan III and Sudan IV in hot chilli products. J Chromatogr A 2004; 1042 (1–2): 123-130
  • 18 Singh RM, Saini PK, Mathur SC, Singh GN, Lal B. Development and validation of a RP-HPLC method for estimation of montelukast sodium in bulk and in tablet dosage form. Indian J Pharm Sci 2010; 72 (02) 235-237
  • 19 Wichitnithad W, Jongaroonngamsang N, Pummangura S, Rojsitthisak P. A simple isocratic HPLC method for the simultaneous determination of curcuminoids in commercial turmeric extracts. Phytochem Anal 2009; 20 (04) 314-319
  • 20 Panchal CR, Prajapati Y, Sakhreliya MB. Development and validation of stability Indicating RP-HPLC method for estimation etizolam in tablet dosage form. J Pharm Sci Bio Sci Res. 2014; 3 (04) 270-275
  • 21 Kanta N, Sahu M, Srinivasa P, Ghosh G. Validation of stability indicating RP-HPLC method for the estimation of mesalamine in bulk and tablet dosage form. Pharm Methods 2014; 13 (04) 56-61
  • 22 Gbylik-Sikorska M, Sniegocki T, Posyniak A. Determination of neonicotinoid insecticides and their metabolites in honey bee and honey by liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 990 (990) 132-140